Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von CandyButcher 

Johnson & Johnson diskutieren

Johnson & Johnson

WKN: 853260 / Symbol: JNJ / Name: Johnson & Johnson / Aktie / Pharmazeutika / Large Cap /

151,70 €
1,21 %

Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,60 %
Kursziel 199,99
Veränderung
Endet am 01.07.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,43 %
Kursziel 169,72
Veränderung
Endet am 19.07.25

Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at TD Cowen from $195.00 to $185.00. They now have a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,23 %
Kursziel 161,96
Veränderung
Endet am 30.07.25

Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $175.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,25 %
Kursziel 199,00
Veränderung
Endet am 30.07.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,80 %
Kursziel 196,23
Veränderung
Endet am 05.08.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,46 %
Kursziel 194,53
Veränderung
Endet am 03.09.25

Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat